Various movements are afoot in the field of global health: from the collective control of epidemics to the personalization of disease; from trial and error to the standardization of evidence and policy; from health as a public good to the pharmaceuticalization of health care; from governmental detachment to the industrialization of the nongovernmental sector and a privatized politics of survival. Alongside them, critical questions abound: Has the biopolitical morphed into a multilevel turf war of private versus public stakeholders battling over the utility of government? Where does this leave the majority and the “surplus” poor and diseased subjects who are not targets of specific interventions? Is their biomedical rehabilitation “futile” in a world where health policies are increasingly oriented by market principles? How does this underside of global health speak to the decline of civil society as a viable “transactional locus” for the guarantee of social justice?...